Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAST trial of lithium for treatment-resistant depression with suicide risk
2009-011409-17Phase 4Completed
- Sponsor
- Azienda Ospedaliera Universitaria Integrata Verona
- Start
- May 2009
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lithium in treatment-resistant depression (TRD) and major depressive disorder (MDD) (2 arms), sponsored by Azienda Ospedaliera Universitaria Integrata Verona. Primary endpoint: Composite suicidal behavior outcome. Started May 2009; status: completed.
02
Drugs
lithium
03
Conditions
treatment-resistant depression (TRD)major depressive disorder (MDD)
Beyond the preview
Go deeper on 2009-011409-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011409-17.